The AffyImmune Therapeutics company source record lists 12 employees. The visible AffyImmune Therapeutics management graph includes:
Related company intelligence for AffyImmune Therapeutics
2 same-industry peers
10 with employee estimates
10 with websites
10 with social profiles
4 peer evidence types
Peer evidence source coverage
4 source-backed evidence types support this related-company graph.
same-industry peers, employee benchmarks, website records, and social profiles
Same-industry peers
2 / 10
2 of 10 related companies share this company's industry classification.
Employee benchmarks
10 / 10
10 of 10 related companies include employee estimates.
Website records
10 / 10
10 of 10 related companies include official website records.
Social profiles
10 / 10
10 of 10 related companies include company social profile signals.
Peer link quality filter
High-confidence peer link set
10 related companies met the 2-signal peer-link threshold. Eligible peers average 4.0 source-backed signals.
10
eligible
0
filtered
4.0
avg signals
Peer comparison matrix
Limited peer comparison
Compares this company with related-company evidence across employee scale and peer graph evidence.
employee scale and peer graph evidence
Employee scale
Smaller than most related peers
This company
12 employees
Related peers
116 median peer employees
9 of 10 related employee-estimated peers are higher.
10 related companies with employee estimates
Peer graph evidence
Multi-signal peer benchmark evidence
This company
Benchmark-ready peer graph
Related peers
3 benchmark dimensions
Peer benchmark combines 10 related companies with peer graph strength, size benchmark, and size position. Underlying peer graph includes 4 evidence types: industry context, employee benchmarks, website records, social profiles.
industry context, employee benchmarks, website records, social profiles
Peer benchmark evidence
Multi-signal peer benchmark evidence
Peer benchmark combines 10 related companies with peer graph strength, size benchmark, and size position. Underlying peer graph includes 4 evidence types: industry context, employee benchmarks, website records, social profiles.
peer graph strength
size benchmark
size position
Peer position benchmark
Employee-scale peer position benchmark
Peer-position benchmark shows employee scale above 0% of 10 comparable related peers.
Directional peer-position evidence:
Peer-position evidence combines employee scale above 0% of 10 comparable related peers from related-company records.
Employee scale: 0%
Peer graph strength
Benchmark-ready peer graph
Related peer graph has industry context, employee benchmarks, website records, and social profiles across 10 related companies.
Peer median size
116 employees
Largest peer by size
ElevateBio
531 employees
AffyImmune Therapeutics size signal
12 employees
Peer size comparison
9 larger · 0 smaller
Peer scale position
Smaller than most related peers
9 of 10 related employee-estimated peers are higher.
AffyImmune Therapeutics people graph sample
-
Daniel Janse
Chief Executive Officer at Affyimmune
Greater Boston, United States12 email signals across 11 non-official domains2 phone signals available
-
Gang Song
Chairman of the Board at Pillar
Newton Centre, Massachusetts, United States3 email signals across 2 non-official domains2 phone signals available
-
-
How AeroLeads builds company intelligence
Use source-backed company records
AeroLeads combines company source fields, workforce samples, email-pattern aggregates, and related-company records when those signals are available.
Show only available evidence
Blank source fields are omitted. Contact channels are summarized as signals, with raw email addresses and phone numbers masked on public pages.
Compare useful company context
Related company, market, workforce, technology, and management signals help turn a static company listing into a company intelligence page.
Contact research
AeroLeads intelligence
Review reachable contact coverage for AffyImmune Therapeutics
AeroLeads maps 2 visible contact signals for AffyImmune Therapeutics. Coverage is multi-channel contact coverage.